40
Participants
Start Date
October 25, 2018
Primary Completion Date
February 15, 2022
Study Completion Date
June 15, 2022
Ocoxin-Viusid
Ocoxin-Viusid group (Experimental): Oral solution Ocoxin-Viusid (30 ml vials) were used at a rate of 60ml / day (1 vial every 12 hours), preferably administered after breakfast and dinner. The treatment will start a week before start Chemotheray treatment (CT) and, It will maintenance until 3 weeks after finished the last cycle of CT (3 cycles of CT of Carboplatin/Paclitaxel or Cisplatin/ Paclitaxel with neoadjuvant intent).
National Institute of Oncology and Radiobiology (INOR), Havana
Catalysis SL
INDUSTRY